Immune Cell Activation and Co-X-irradiation Effect of Eleutherococcus senticosus Maxim Root

가시오갈피 뿌리의 면역세포 활성 및 방사선 병용효과

  • Kwon, Hyoung-Cheol (Department of Radiation Oncology and Institute for Medical Science, Medical School, Chonbuk National University) ;
  • Park, Jeong-Seob (Department of Herb Science, Iksan National College) ;
  • Choi, Dong-Seong (Department of Food Biotechnology, Woosuk University)
  • 권형철 (전북대학교 의학전문대학원 방사선종양학교실, 의과학연구소) ;
  • 박정섭 (익산대학 약재개발과) ;
  • 최동성 (우석대학교 식품생명공학과)
  • Published : 2007.09.30

Abstract

Purpose: This study was performed to investigate the effects of immune cell activation and the antitumor effect for the combination of treatment with X-irradiation and E/eutherococcus senticosus Maxim Root (ESMR) on mouse tumor cells. Materials and Methods: ESMR (250g) was extracted with 80% methanol, concentrated under decompression and lyophilized. To determine whether ESMR is able to activate the immune cells or not, the proliferation of splenocytes in vitro and the number of B cells and T cells in splenic lymphocytes in ESMR-pretreated mice were evaluated. X-irradiation was given to the mouse fibrosarcoma tumor cells (FSa II) by 250 kv X-irradiation machine. The cytotoxicity of ESMR was evaluated from its ability to reduce the clonogenecity of FSa II cells. In X-irradiation alone group, each 2, 4, 6 and 8 Gy was given to FSa II cells. In X-irradiation with ESMR group, 0.2 mg/ml of ESMR was exposed to FSa II cells for 1 hour before X-irradiation. Results: The proliferation of cultured mouse splenocytes and thymocytes were enhanced by the addition of ESMR in vitro. The number of B cells and T cells in mouse splenic lymphocytes was significantly increased in ESMR pretreated mice in vivo. In FSa II cells that received a combination of 0.2 mg/ml of ESMR with X-irradiation exposure, the survival fraction with a dose of 2, 4 and 6 Gy was $0.39{\pm}0.005$, $0.22{\pm}0.005$ and $0.06{\pm}0.007$, respectively. For FSa II cells treated with X-irradiation alone, the survival fraction with a dose of 2, 4 and 6 Gy was $0.76{\pm}0.02$, $0.47{\pm}0.008$ and $0.37{\pm}0.01$. The difference in the survival fraction of the mouse FSa II cells treated with and without ESMR was statistically significant (p<0.05). Conclusion: Treatment with ESMR increased cell viability of mouse splenocytes in vitro and especially the subpopulation of B cells and T cells in splenocytes in ESMR-pretreated mice. However, treatment with ESMR did not increase the level of Th and Tc subpopulations in the thymocytes. Treatment with the combination of ESMR and X-irradiation was more cytotoxic to mouse tumor cells than treatment with X-irradiation alone; this finding was statistically significant.

목적 : 가시오갈피 뿌리 추출물(Extract of Eleuthrococcus senticosus Maxim root, ESMR)의 면역세포의 활성에 미치는 효과와 마우스 종양세포에서 세포독성 및 방사선 병용효과를 알기위해서 본 연구를 시행하였다. 대상 및 방법: 가시오갈피 뿌리(250 g)를 80% 메탄올로 추출한 다음, 감압농축 및 동결과정을 통해 분획을 얻었다. 세포 주는 섬유육종세포를 이용하였으며, 방사선조사는 저 에너지(250 KV)용 방사선 기기를 사용 하였다. 가시오갈피 추출물의 면역세포에 미치는 활성효과를 알아보기 위해서 마우스 비장 및 흉선세포의 생존율 측정과 비장 및 흉선림프구 아집단을 측정하였다. 세포독성 정도를 알아보기 위하여 clonogenic assay법을 이용하였다. 방사선조사 단독군의 경우 2, 4 및 6 Gy를 마우스 섬유육종세포(FSa II)에 조사하였으며, 가시오갈피와 방사선 병용군의 경우 0.2 mg/ml 농도의 가시오갈피를 방사선조사 1시간 전에 마우스 섬유육종세포에 접촉시켰다. 결 과: 가시오갈피 /뿌리 추출물 각각 10 ${\mu}g/ml$$100{\mu}g/ml$을 첨가한 마우스 비장 및 흉선세포 생존율은 다음과 같았다. 마우스 비장세포는 각각 $8.8{\pm}1.7%$$37.7{\pm}2.1%$로 증가하였으며, 흉선세포에서는 100 ${\mu}g/ml$에서 $16.7{\pm}1.6%$로 증가하였다. ESMR을 경구 투여한 마우스 비장 및 흉선림프구는 다음과 같았다. 마우스 비장세포의 B cell은 41.5 $({\pm}1.3)$에서 46.0 $({\pm}1.5)%$로, T cell은 16.9 $({\pm}0.9)$에서 22.3 $({\pm}1.2)%$로 증가하였으며, 특히 Helper T (Th) cell은 10.4 10.4 $({\pm}0.7)$에서 14.2 $({\pm}0.8)%$로, Cytotoxic T (Tc) cell은 3.6 $({\pm}0.4)$에서 5.6 $({\pm}0.3)%$로 증가하였다. 그러나 마우스 흉선세포에서 T림프구의 증가율은 거의 보이지 않았다. 마우스 섬유육종 세포에서 ESMR의 세포독성을 나타내는 생존분율은 0.2, 2.0 mg/m에서 각각 $0.36{\pm}0.02$, $0.05{\pm}0.02$으로 나타났다. 마우스 섬유육종 세포를 접종한 마우스에 ESMR 0.2 mg/ml 농도를 1시간 동안 접촉시킨 다음, 방사선조사량 2, 4 및 6 Gy를 조사한 후 얻은 생존분물은 0.39, 0.22 및 0.06이었으며, 방사선조사 단독군의 경우는 0.76, 0.47 및 0.37로 나타났다. 그리고 두 군간의 차이는 통계학적 의미를 나타냈다(p<0.05). 결 론: 가시오갈피 뿌리 추출물은 in vitro 실험에서 마우스 비장세포의 생존율을 증가시켰다. In vivo 실험에서는 마우스 비장 내 B세포 및 T세포를 증가시켰으나, 마우스 흉선세포에 대해서는 증가를 보이지 않았다. ESMR은 마우스 섬유육종 세포에 대해 강한 세포독성 효과를 나타냈다. FSa II를 접종한 마우스에서 방사선 단독 보다 ESMR을 병용한 경우 방사선에 의한 세포손상이 약 50% 이상 증가되었으며, 두 군간의 차이는 통계학적 의미를 나타냈다(p<0.05).

Keywords

References

  1. http://rex.nci.nih.gov/NCI_Pub_Interface/raterisk/rates28.html
  2. Breckhmann II, Dardymov ID. New substances of plant origin which increase nonspecific resistance. Ann Rev Pharmacol 1969;9:419-430 https://doi.org/10.1146/annurev.pa.09.040169.002223
  3. Davydov M, Kirkorian AD. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol 2000;72:345-393 https://doi.org/10.1016/S0378-8741(00)00181-1
  4. Deyama T, Nishibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommis and Siberian ginseng. Acta Pharmacol 2001;22:1057-1070
  5. Ruijun Z, Jinkang Q, Gnanghua Y, Baozhen W, Xiulan W. Medicinal protection with Chinese herb-compound against radiation damage. Aviation, Space Environ Med 1990;61:729-731
  6. Hibasami H, Fugikawa T, Takeda S, et al. Induction of apoptosis by Acanthopanax senticosus HARMS and its component, sesamin in human stomach cancer KATO III cells. Oncol Rep 2000;7:1213-1216
  7. Strel'chuk SI. Anti mutagenic effect of Eleutherococus extracts plants treated with ethylmethane sulfonate. Tsitol Genet 1987;21:136-139
  8. Salikhova RA, Umnova NV, Fomina MM, Poroshenko GG. An anti mutagenicity study of bio-ginseng. Izvestiia Akademii Nauk. Serria Biologicheskaia 1994;1:48- 55
  9. Park JS, Oh CH, Ko HY, Choi DS. Anti mutation effect of Eleutherococcus senticosus. Extract J Korean Soc of Food Science and Technology. 2002;34:1110- 1114
  10. Park JS, Ahn BY, Ko HY, Choi DS. Anti mutation effect of Eleutherococcus senticosus Extract against direct mutational source. Korean J Biotechnol Bioeng 2003;18:165-170
  11. Kwon HC, Kim JS. Antitumor effect of korean ginseng: cytotoxicity and tumor growth delay (1). The Jeonbuk University Medical Journal 1996;20:97-102
  12. Kwon HC, Kim JS, Choi KC, Choi DS, Song CW. Antitumor effect of Ganoderma lucidum; Cytotoxicity and Tumor growth delay (1). J Korean Soc Ther Radiol 1994;12:301-305
  13. Mosmann T. Rapid colorimetric assay fot cellulat growth and survial application to proliferation and cytotoxic assays. J Immunol Methods 1983;65:55-63 https://doi.org/10.1016/0022-1759(83)90303-4
  14. Shortman K, Backson H. The differentiation of T lymphocytes, proliferation kinetics and interrelationships of subpopulations of mouse thymus cells. Cell Immunol 1974;12:230-246 https://doi.org/10.1016/0008-8749(74)90075-6
  15. Rhee JG, Schuman VL, Song CW. Difference in the thermotolerance of mouse mammary carcinoma cells in vivo and vitro. Cancer Res 1997;47:2571-2575
  16. Hall EJ. Radiobiology for the radiobiologist. 3rd ed. Philadelphia, PA: JB Lipoincott Co. 1998:18-38
  17. Jang SK, Kim JH, Jeong YS. Immune activity and antitumor effect of Korean red ginseng. Korean J Ginseng Sci 1994;18:151-159
  18. Nakata, H, Kikuchi Y, Tode T. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 1998;89:733-740 https://doi.org/10.1111/j.1349-7006.1998.tb03278.x
  19. Shim SH, Koh HY. Polyacetylene compound from Panax Gin-seng C.A. Meyer. Korean J Ginseng Sci 1983;4:183-188
  20. Kim SJ, Chang KS. Separating of Falcarinol from Acanthopanax senticosus. Korean J Food Sci Technol 2005;37:360-363
  21. Hiroaka, N, Chang, JI, Bohm RL, Bohm BA. Furanocoumarin and polyacetylenic compound composition of wild Glehnia littoralis in North America. Biochem System Ecol 2002;30:321-325 https://doi.org/10.1016/S0305-1978(01)00104-1
  22. Sohn HJ, Jand GC, Rah HH. Lee KS. Occurrence of falcarinol (n-heptadeca-1,9-dien-4,6-diyn-3-ol) in the umbelliferous plants. J Korean Agric Chem Soc 1990; 33:120-124